These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1323916

  • 1. [Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan)].
    Tuba Z, Mahó S.
    Acta Pharm Hung; 1992 May; 62(3):73-81. PubMed ID: 1323916
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinicopharmacology of Arduan].
    Mészáros C.
    Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacologic effects of pipecuronium bromide (Arduan)].
    Kárpáti E, Bíró K.
    Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of steroids. Part 44: Analytical investigation of the intermediates of the synthesis of pipecuronium bromide (Arduan)].
    Laukó A, Horváth P, Trischler F, Görög S.
    Acta Pharm Hung; 1992 May; 62(3):82-7. PubMed ID: 1323917
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E, Biró K.
    Arzneimittelforschung; 1980 May; 30(2a):346-57. PubMed ID: 6155921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical experiences with pipecuronium bromide.
    Boros M, Szenohradszky J, Kertész A, Marosi G, Tutsek L.
    Acta Chir Hung; 1983 May; 24(4):207-14. PubMed ID: 6322488
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans.
    Tassonyi E, Szabó G, Vereczkey L.
    Arzneimittelforschung; 1981 May; 31(10):1754-6. PubMed ID: 6274362
    [Abstract] [Full Text] [Related]

  • 16. Pipecuronium bromide.
    Benad G, Hofmockel R.
    Br J Hosp Med; 1991 May; 45(5):308. PubMed ID: 1648418
    [No Abstract] [Full Text] [Related]

  • 17. Disposition of pipecurium bromide in rats.
    Vereczkey L, Szporny L.
    Arzneimittelforschung; 1980 May; 30(2a):364-6. PubMed ID: 6248080
    [Abstract] [Full Text] [Related]

  • 18. First clinical experience with a new neuromuscular blocker pipecurium bromide.
    Alánt O, Darvas K, Pulay I, Weltner J, Bihari I.
    Arzneimittelforschung; 1980 May; 30(2a):374-9. PubMed ID: 6248083
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.